| scholarly article | Q13442814 |
| P50 | author | Christopher Overall | Q42843211 |
| P2093 | author name string | G Angus McQuibban | |
| John L Wallace | |||
| Ian Clark-Lewis | |||
| Julie P Wong | |||
| Jiang-Hong Gong | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1160-1167 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo | |
| P478 | volume | 100 |
| Q33856359 | 2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting |
| Q41828378 | A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis |
| Q27690654 | A novel role for bioactive lipids in stem cell mobilization during cardiac ischemia: new paradigms in thrombosis: novel mediators and biomarkers |
| Q41470056 | AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9. |
| Q35956613 | Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice |
| Q42914570 | Activated protein C mediates a healing phenotype in cultured tenocytes |
| Q26830499 | Activated protein C: A regulator of human skin epidermal keratinocyte function |
| Q38008342 | Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair |
| Q39501938 | Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis |
| Q33655907 | Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma |
| Q34964361 | Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage |
| Q41314097 | Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke |
| Q49843962 | Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population. |
| Q37376668 | Astrocyte elevated gene-1 is associated with metastasis in head and neck squamous cell carcinoma through p65 phosphorylation and upregulation of MMP1 |
| Q25255834 | Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. |
| Q34407655 | Basis for substrate recognition and distinction by matrix metalloproteinases |
| Q36853117 | Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction |
| Q39432022 | Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. |
| Q34172720 | Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities |
| Q34994320 | Broad coverage identification of multiple proteolytic cleavage site sequences in complex high molecular weight proteins using quantitative proteomics as a complement to edman sequencing |
| Q42428975 | Burn injury reveals altered phenotype in mannan-binding lectin-deficient mice |
| Q55382749 | C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease. |
| Q37602101 | CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms |
| Q41835095 | CCL2/MCP-1 modulation of microglial activation and proliferation. |
| Q60916286 | CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection |
| Q80860589 | CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation |
| Q61942655 | Cathelicidin Related Antimicrobial Peptide (CRAMP) Enhances Bone Marrow Cell Retention and Attenuates Cardiac Dysfunction in a Mouse Model of Myocardial Infarction |
| Q90417537 | Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review |
| Q26778690 | Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds |
| Q38274693 | Chemokines in tuberculosis: the good, the bad and the ugly |
| Q40160262 | Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts |
| Q90324721 | Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort |
| Q40374354 | Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes. |
| Q33233386 | Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma |
| Q50086153 | Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage. |
| Q64252263 | Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development |
| Q35592746 | Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines |
| Q35842486 | Deep sequencing of the uterine immune response to bacteria during the equine oestrous cycle. |
| Q35776317 | Deficiency of matrix metalloproteinase-13 increases inflammation after acute lung injury |
| Q35875120 | Development of a mathematical model to describe the transport of monocyte chemoattractant protein-1 through a three-dimensional collagen matrix |
| Q37101595 | Differential effects of shear stress and cyclic strain on Sp1 phosphorylation by protein kinase Czeta modulates membrane type 1-matrix metalloproteinase in endothelial cells |
| Q35929334 | Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter |
| Q90457803 | Disruption of GPR35 Exacerbates Dextran Sulfate Sodium-Induced Colitis in Mice |
| Q26825368 | Diverse functions of matrix metalloproteinases during fibrosis |
| Q37707609 | Diverse macrophage populations mediate acute lung inflammation and resolution |
| Q36537738 | Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniae |
| Q36176901 | Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation |
| Q82760154 | Endogenous protein C is essential for the functional integrity of human endothelial cells |
| Q53108154 | Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice. |
| Q28508876 | Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia |
| Q37164277 | Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy |
| Q64102301 | Evidence of Different IL-1β Activation Pathways in Innate Immune Cells From Indeterminate and Cardiac Patients With Chronic Chagas Disease |
| Q40874989 | Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation |
| Q37553843 | Extracellular matrix metalloproteinase inducer enhances host resistance against pseudomonas aeruginosa infection through MAPK signaling pathway |
| Q92513107 | Factors Associated with RANTES Concentration in Cardiovascular Disease Patients |
| Q39368250 | Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes |
| Q55045366 | Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence. |
| Q36815449 | HIV-1 and the immune response to TB. |
| Q37178315 | Heat shock protein 70 secretion by neonatal tracheal tissue during mechanical ventilation: association with indices of tissue function and modeling. |
| Q24595036 | Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies |
| Q64100353 | Identification of fibrinogen as a natural inhibitor of MMP-2 |
| Q54502519 | Immunological investigation of the hepatic tissue from infants with biliary atresia. |
| Q37295174 | In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon's fibroblasts: comparisons with mitomycin C. |
| Q55380020 | In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation. |
| Q49155266 | Induction of matrix metalloproteinase-9 in mice during Toxocara canis larvae migration. |
| Q37171985 | Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients |
| Q64992814 | Intratibial injection of patient-derived tumor cells from giant cell tumor of bone elicits osteolytic reaction in nude mouse. |
| Q34512378 | Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment |
| Q28469158 | LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity |
| Q36715904 | Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization |
| Q33396615 | MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages |
| Q92987609 | MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues |
| Q99552003 | MMP2 as an independent prognostic stratifier in oral cavity cancers |
| Q37403743 | MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis |
| Q92575076 | MMPs and ADAMs in neurological infectious diseases and multiple sclerosis |
| Q37554550 | Macrophage cathepsin K promotes prostate tumor progression in bone |
| Q36598477 | Macrophage differentiation and polarization on a decellularized pericardial biomaterial |
| Q44899123 | Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo |
| Q92502869 | Matrix Metalloproteases as Influencers of the Cells' Social Media |
| Q35768956 | Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice |
| Q39144302 | Matrix Metalloproteinases as Regulators of Periodontal Inflammation |
| Q36761849 | Matrix metalloproteases: underutilized targets for drug delivery |
| Q52561219 | Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. |
| Q37283984 | Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status |
| Q35221967 | Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells |
| Q37150788 | Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation |
| Q34009051 | Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata. |
| Q42427197 | Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice |
| Q34161592 | Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants |
| Q29618747 | Matrix metalloproteinases and the regulation of tissue remodelling |
| Q36449536 | Matrix metalloproteinases as modulators of inflammation |
| Q35830977 | Matrix metalloproteinases in liver injury, repair and fibrosis |
| Q36712749 | Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted |
| Q34199345 | Matrix metalloproteinases in tumorigenesis: an evolving paradigm. |
| Q92034033 | Matrix metalloproteinases inactivate the proinflammatory functions of secreted moonlighting tryptophanyl-tRNA synthetase |
| Q29619858 | Matrix metalloproteinases: regulators of the tumor microenvironment |
| Q33919160 | Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis |
| Q37224415 | Mechanotransduction and cartilage integrity |
| Q35587684 | Membrane associated proteases and their inhibitors in tumour angiogenesis |
| Q36911913 | Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis |
| Q37033574 | Metalloproteinases and their inhibitors: regulators of wound healing |
| Q35553483 | Metalloproteinases, inflammation, and rheumatoid arthritis. |
| Q35310572 | Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis |
| Q33963030 | Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification |
| Q38139823 | Monocyte chemoattractant protein-1 and the blood-brain barrier |
| Q34488791 | Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP function |
| Q27321403 | Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke |
| Q36634172 | Multiple roles for chemokines in the pathogenesis of SIV infection |
| Q30387118 | Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics |
| Q33598951 | Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response |
| Q37820192 | New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies |
| Q37402901 | Oestrous cycle-dependent equine uterine immune response to induced infectious endometritis |
| Q37407320 | Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines |
| Q37760424 | Phagocyte partnership during the onset and resolution of inflammation. |
| Q36804675 | Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding |
| Q35007715 | Physiology and pathophysiology of matrix metalloproteases. |
| Q35166512 | Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study |
| Q38119874 | Platelet-rich plasma and the elimination of neuropathic pain |
| Q50875254 | Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration. |
| Q90432906 | Pro-Inflammatory Priming of Umbilical Cord Mesenchymal Stromal Cells Alters the Protein Cargo of Their Extracellular Vesicles |
| Q24678647 | Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors |
| Q36803400 | Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury |
| Q36862601 | Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators |
| Q90203377 | Prostatic epithelial cells and their high expressions of CKIP-1 affect the TGF-β1 expression levels which might reduce the scar formation in remodeling stage at prostatic urethral wounds after wound repair |
| Q37760881 | Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection |
| Q41682687 | Proteolytic processing and inactivation of CCL2/MCP-1 by meprins |
| Q35539844 | Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration |
| Q36967346 | Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation |
| Q34380801 | Pseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus), but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus). |
| Q37082562 | Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease |
| Q54967102 | Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. |
| Q28583577 | Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus |
| Q28072580 | Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26 |
| Q26747410 | Resolution of Inflammation: What Controls Its Onset? |
| Q26852569 | Resolution of inflammation: an integrated view |
| Q35217468 | Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection |
| Q37540188 | Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors |
| Q34248959 | Role of tumor necrosis factor-alpha in wound repair in human vocal fold fibroblasts |
| Q61799021 | S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy |
| Q36324730 | Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. |
| Q90484463 | Self-Generated Gradients Yield Exceptionally Robust Steering Cues |
| Q33833881 | Senescent cells as a source of inflammatory factors for tumor progression |
| Q39449103 | Senescent cells: an emerging target for diseases of ageing |
| Q39953992 | Shedding of Syndecan-1/CXCL1 Complexes by Matrix Metalloproteinase 7 Functions as an Epithelial Checkpoint of Neutrophil Activation. |
| Q38647749 | Successes and failures of chemokine-pathway targeting in rheumatoid arthritis |
| Q80625346 | Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes |
| Q37075774 | Synovial fluid matrix metalloproteinase-2 and -9 activities in dogs suffering from joint disorders. |
| Q35146748 | Systemic and mucosal immune reactivity upon Mycobacterium avium ssp. paratuberculosis infection in mice |
| Q37412450 | Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation |
| Q38174997 | Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis |
| Q37774392 | Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. |
| Q35221324 | Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation |
| Q40333177 | The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity |
| Q26741200 | The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke |
| Q41151771 | The effect of local IL-4 delivery or CCL2 blockade on implant fixation and bone structural properties in a mouse model of wear particle induced osteolysis |
| Q44923128 | The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis |
| Q28294058 | The impact of the extracellular matrix on inflammation |
| Q36038807 | The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions. |
| Q38169568 | The mercurial nature of neutrophils: still an enigma in ARDS? |
| Q30352025 | The multiple faces of CCL13 in immunity and inflammation. |
| Q36264888 | The paradox of matrix metalloproteinases in infectious disease |
| Q37594948 | The role of bioactive lipids in stem cell mobilization and homing: novel therapeutics for myocardial ischemia |
| Q29620106 | The senescence-associated secretory phenotype: the dark side of tumor suppression |
| Q37415953 | The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules |
| Q36503385 | The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10. |
| Q91810892 | Transcriptome Meta-Analysis Deciphers a Dysregulation in Immune Response-Associated Gene Signatures during Sepsis |
| Q42278117 | Transcriptome Profiling of IL-17A Preactivated Mesenchymal Stem Cells: A Comparative Study to Unmodified and IFN-γ Modified Mesenchymal Stem Cells |
| Q37090871 | Transcriptome profiling of primary murine monocytes, lung macrophages and lung dendritic cells reveals a distinct expression of genes involved in cell trafficking |
| Q48091188 | Using biomaterials to modulate chemotactic signaling for central nervous system repair |
| Q47139628 | VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes |
| Q37411630 | Vaginal Lactoferrin Modulates PGE2, MMP-9, MMP-2, and TIMP-1 Amniotic Fluid Concentrations |
| Q36262572 | alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy |
| Q63727538 | cAIMP administration in humanized mice induces a chimerization‐level‐dependent STING response |
Search more.